Department of Psychiatry & Psychology Grand Rounds/#41072015
Wednesday, March 2, 2016
12:00-1:00 p.m., Gonda 5-104 Leighton Lecture Hall
Lunch will be served on a first come basis
1st Presenter
Anxiety Disorders in Primary Care: Integrated Behavioral Health (IBH) Outcomes
Julia Craner, Ph.D., LP
Introduction
Julia Craner is a second-year Clinical Health Psychology Fellow and Assistant Professor of Psychology in the Mayo Clinic College of Medicine. She completed her undergraduate degree at the University of Michigan and went on to obtain her M.A. and Ph.D. in Clinical Psychology at the University of Maine. She has accepted position at Spectrum Health Medical Group in Grand Rapids, MI to begin after she completes her fellowship this year. Her primary clinical focus is the management of anxiety, mood, and behavioral health concerns in primary care and other medical settings. Research interests include the interaction of biopsychosocial contributions to health, particularly the manner in which individuals interpret and respond to physical and emotional changes. She has presented her research at national and international conferences, and has published in several peer-reviewed journals.
Learning Objectives
1. Describe the rationale for management of anxiety disorders in primary care settings
2. Identify evidence-based behavioral approaches for treatment of anxiety disorders
3. Evaluate outcomes of brief psychotherapy services offered in primary care
2nd Presenter
Epigenetic regulation of metabotropic glutamate receptors in bipolar disorder
Jacquetta Blacker, B.M.B.Ch.
Introduction
Dr. Blacker earned her medical degree from the University of Oxford while also obtaining a BA and MA in Physiological Sciences. She researched in vitro models of sepsis at Dr. Richard Boyd’s laboratory in the Human Anatomy Department at Oxford. She worked as an anatomy teacher at the University of Cambridge and a surgical trainee in the United Kingdom before returning to the US. She is in her final year of the residency program of the Department of Psychiatry and Psychology at Mayo Clinic, where she is currently Chief Resident and is a member of the research track. Her research mentor within the research track program is Dr. Marin Veldic and they have been examining epigenetic modifications of metabotropic glutamate receptors (particularly mGlu2 and mGlu3) in mood disorders, especially bipolar disorder. Her additional interests include chronic mood and anxiety disorders in children and adolescents, particularly in surgical subpopulations. She has presented research findings at several national and international conferences. She will be starting Child and Adolescent fellowship next year.
Learning Objectives
Understand the field of epigenetics and the molecular mechanisms involved
Appreciate the applications of epigenetic research to psychiatric conditions
Recognize the current state of knowledge of epigenetic regulation of metabotropic glutamate receptors in bipolar disorder
Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. MedHub will be implemented for all post presentation surveys. Your name and e-mail are not linked to your evaluation. Identifiers are tracked separately for attendance records only. To document your attendance, please send an email to rstpsychgr@mayo.edu. The badge reader should continue to be utilized for Gonda and Sister Helen Hayes locations.
Credit Statements
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
Relevant financial relationship(s) with industry: None
No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, M.D., Patricia Maus, M.D., Amber Pearson, Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Georgina Rink
Julia Craner, Ph.D. & Jacquetta Blacker, B.M.B. Ch.
References to off-label usage(s) of pharmaceuticals or instruments in their presentation: None
Questions regarding this program can be directed to Amber Pearson at Pearson.Amber@mayo.edu.

Facebook
X
LinkedIn
Forward